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Up-regulation of tubular epithelial interleukin-12 in autoimmune
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Up-regulation of tubular epithelial interleukin-12 in autoimmune
MRL-Fas" juice with renal injury. Phagocyte-derived interleukin-12
(IL-12) is a key cytokine that induces the development of an effective Thi
type immune response in various inflammatoiy and infectious disorders.
To determine the importance of IL-12 in the pathogenesis of autoimmune
renal injury we examined the renal production of this heterodimeric
cytokine in the MRL-Fas1" lupus nephritis model. Compared with normal
mice, RT-PCR products encoding both the p35 and p40 subunits of IL-12
were markedly increased in the kidney of MRL-Fas". Immunofluores-
cencc staining demonstrated expression of the IL-12 p75 heterodimer on
isolated infiltrating mononuclear cells and also on proximal tubular
epithelial cells in MRL-Fas" but less in normal mice kidneys. The
enhanced expression of IL-12 correlated with an increased intrarenal
transcription of IFN-y. The p35 and p40 transcripts and soluble IL-12 p75
protein were also produced by cultured TEC. In addition, membrane
bound IL-12 was detected on TEC. We conclude that IL-12 production is
significantly up-regulated in MRL-Fas'° lupus nephritis. In addition to
mononuclear cells, TEC are an important source of IL-12 and could
thereby participate in the development of a Thl type immune response in
autoimmunc renal injury.
MRL-Fas4" mice represent an excellent model to study the
pathogenesis of lupus nephritis [1, 2]. These mice develop severe
immune complex-mediated glomerulonephritis and die of renal
failure between 5 to 8 months of age 131. Defective transcription
of the apoptosis gene encoding Fas (CD95) causes massive
lymphoproliferation of double-negative (CD4—CD8—) T cells in
mice with the lprllpr genotype [4, 5]. These double-negative T cells
are a rich source of proinflammatory cytokines, including TNF-a
and IFN-y [6, 7]. In addition, MRL-Fas" mice also display
proinfiammatory alterations in the intrarenal cytokine network [8,
9].
Alterations in the cytokine network are characteristic of many
immune-mediated disorders [10]. Local cytokine production pat-
terns orient the immune response towards cell-mediated (Thi) or
humoral(Th2) immunity [11, 12]. The phagocyte-derived cytokine
IL-12 is a particularly effective inducer of a Thi type immune
response, whereas IL-4 and IL-b promote the induction of a Th2
type immune response [13, 14]. Cytokines produced by Thi type
lymphocytes may play a major role in the pathogenesis of auto-
immune diseases [14, 151.
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Interleukin-12 (IL-12) is an inducible cytokine whose diverse
characteristics and biological functions have been reviewed re-
cently [16, 17]. Its heterodimeric structure is unique among the
cytokines. The 35 kDa (p35) and a 40 kDa (p40) subunits are
covalently linked to form the bioactive IL-12 (p75) cytokine. The
murine and human IL-12 genes encoding the two subunits have
been cloned and expressed [18, 19] and were mapped to separate
chromosomes [20, 21]. The expression of p35 and p40 is regulated
independently. The p35 subunit is produced by many cell types,
whereas p40 expression is usually restricted to phagocytic cells
with antigen presenting abilities. In cells that produce the p75
heterodimer the rate of mRNA transcription and protein synthe-
sis for the p40 subunit is much greater than the rate for the p35
subunit. There is evidence that excess free p40 or p40 homodimers
can act as natural IL-12 antagonists competing at the receptor
level with the p75 heterodimer [22, 23].
IL-12 has diverse effects on T cells, including induction and
secretion of eytokines, enhancement of eytotoxic activity and
stimulation of T cell proliferation. IL-12 is a potent direct inducer
of IFN-y acting in synergy with other eytokines to promote the
generation of a Thi type immune response [10, 13]. IL-12 plays a
major role in immune responses by providing a link between
natural resistance (mediated by phagocytic and NK cells) and
adaptive immunity (mediated by T helper, cytotoxic and B cells)
[13]. IL-12's capacity to induce a Thi type of immune response in
vivo has lead to beneficial effects in diverse infectious processes,
particularly against intracellular pathogens and parasites. IL-12
also has prominent antitumor activities in a variety of experimen-
tal models [16, 17]. Furthermore, IL-12 has been implicated in the
pathogenesis of various organ-specific autoimmune diseases by
promoting the development of ThI cells [14].
Because the renal injury of autoimmune MRL-Fas" has not
been assigned to a ThI or a Th2 type immune response we have
examined the expression and function of IL-12 in this lupus
model. Here we demonstrate that IL-12 expression is abundant
within the kidney of MRL-Fas" mice with nephritis. The en-
hanced expression of EL-12 correlates with intrarenal transcrip-
tion of IFN-y and suggests a direct link between these two
cytokines and the development of a Thi type of immune response
in MRL-Fas9". A striking feature is the expression of IL-12 by
renal tubules in MRL-Fas" kidney. Cultured tubular epithelial cells
(TEC) also display IL-12 transcription and p75 protein expres-
sion. Furthermore, membrane-bound 1L-i2 is detected on TEC.
These results suggest that IL-12 produced by renal parenchymal
cells with antigen-presenting capacity such as TEC may modulate
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immune responses in the kidney, promoting a Thi type of immune
response in MRLFash1r and other autoimmune renal diseases.
Methods
Materials
Normal (C57BL/6J and MRL/MpJ-+ +) and autoimmune mice
(MRL/MpJ-Fas" [MRL-Fas1"i) were obtained from the Jack-
son Laboratories (Bar Harbor, ME, USA). Tissue culture re-
agents were purchased from Life Technologies (Gaithersburg,
MD, USA) and chemicals from Sigma Chemical Co. (St. Louis,
MO, USA). The rat anti-murine IL-12 mAbs 9A5 (anti-p75) and
5C3 (anti-p40) were provided by Dr. D.H. Presky (Roche Phar-
maceuticals, Nutley, NJ, USA).
Primers
The following primers were used to assess IL-12 gene expres-
sion [18, 24]: IL-12 p35 sense 5'-GAG GAC TTG AAG ATG
TAC CAG-3' (21-mer), IL-12 p35 anti-sense 5'-TCC TAT CTG
TGT GAG GAG GGC-3', yielding a 321 bp fragment. IL-12 p40
sense 5'-GAC CCT GCC CAT TGA ACT GGC-3' (21-mer),
IL-12 p40 anti-sense 5'-CAA COT TGC ATC CTA GGA TCG-
3', yielding a 415 bp fragment. IFN-y transcription was assessed
using the primers 5'-GAC AAT CAG GCC ATC AGC AAC-3'
(21-mer sense) and 5'-CGC AAT CAC AGT CTF GGC TAA-3'
(21-mer antisense), yielding a 495 bp RT-PCR fragment [25, 26].
The housekeeping gene encoding rat GAPDH was used for
semiquantitative comparison with cytokine transcripts: GAPDH
sense 5'-AAT GCA TCC TGC ACC ACC AA-3' (20-mer),
GAPDH anti-sense 5'-GTA GCC ATA TTC AlIT GTC ATA-3'
(21-mer), yielding a 516 bp fragment [27, 28]. All primer sets were
chosen to encompass an intron to control for amplification of
genomic DNA.
Cell culture
Primary cultures of TEC and the SV40-transformed TEC Cl
and MCT have been described previously [29, 30]. These cells all
display proximal tubular-like characteristics such as alkaline phos-
phatase expression. Primary cultures of rnurine cortical TEC were
grown in modified Ki media containing 5% FBS [29]. Cl cells
were grown in modified Ki media containing 5% FCS, MCT cells
in DMEM containing 10% FBS, 10 mvi Hepes, 100 U/mi penicil-
lin and 100 jsg/ml streptomycin.
RNA extraction
Total RNA was isolated from tissues by homogenization in 4 M
guanidinium isothiocyanate and ultracentrifugation at 35,000 rpm
through a 5.7 M CsC12 layer [31]. Pellets were washed with 70%
ethanol, dissolved in DEPC-treated H20 and quantitated by
measuring the OD at 260 nm. Total RNA was extracted from
cultured TEC by direct lysis in culture dishes with 4 M guani-
dinium isothiocyanate, 0.5% sarcosyl, 0.1 M f3-mercaptoethanol in
25 m sodium citrate (pH 7.0). After phenol/chloroform extrac-
tion, the RNA was precipitated twice with isopropariol and
washed with 70% ethanol [32].
RT-PCR and Southern blotting
One microgram aliquots of total kidney RNA were analyzed by
RT-PCR using a kit (Perkin-Elmer, Branchburg, NJ, USA).
Random hexanucleotide primers (2.5 jsM) and murine leukemia
virus reverse transcriptase (2.5 U/j.tl) were used for cDNA syn-
thesis in 20 sl reaction mixtures containing 1 m of each
nucleotide (dNTP) and 5 mi MgCl2. Following extension at 42°C
for 45 minutes the reverse transcriptase was inactivated at 95°C
for five minutes. PCR was performed in the same tube in a final
100 jl reaction volume by adding 0.15 jsM primers, 0.2 m'vi dNTP,
2 mi MgC12 and 2.5 U of AmpliTaq® DNA polymerase. Cycling
parameters were as follows: denaturation at 94°C for 40 seconds,
annealing at 55°C for 120 seconds, extension at 72°C for 150
seconds over 40 cycles, followed by a terminal extension at 72°C
for seven minutes using a Gene Amp PCR System 2400 thermo-
cycler (Perkin-Elmer). Amplification was linear for all primer sets
tested for a cycle number up to 40. RT-PCR products were
resolved on 1% agarose gels in I x TBE buffer. Gels were stained
with 0.5 jsg/ml ethidium bromide and photographed under UV
light.
To ensure specificity of the amplification products Southern
blot was performed for all RT-PCR reactions. Gels were dena-
tured with 0.5 N NaOH in 1 M NaCl for 30 minutes and neutralized
with 0.5 M Tris-HCI (pH 7.4) in 3 M NaCl for 30 minutes. DNA
transfer onto nylon membranes (Zeta-Probe blotting membranes;
BioRad Laboratories, Hercules, CA, USA) was performed in
10 x SSC. Blots were then prehybridized with 100 sg/m1 sheared
denatured salmon sperm DNA. The cDNA fragments were
radiolabeled using random hexamers and cx-32P dCTP [33]. The
cDNAs encoding murine IL-12 p35 and p40 subunits were
generously provided by Dr. U. Gubler (Roche Pharmaceuticals,
Nutley, NJ, USA). A 470 bp XbaI p35 fragment, a 1055 bp
EcoRI/HindIII p40 fragment and a 650 bp PstI IFN-y fragment
were excised from the plasmids and used for hybridization. Blots
were hybridized overnight at 42°C in 40% formamide, 6 x SSC,
5 x Denhardt's solution and 1% SDS. Blots were then washed
under stringent conditions (final wash in 0.2 X SSC, 1% SDS,
60°C). Following hybridization the blots were exposed to Kodak
X-OMAT AR film. Densitometric analysis of autoradiographs
was performed with the ImageouaNT® software (Molecular
Dynamics, Sunnyvale, CA, USA).
Immunofluorescence staining for IL-12 in murine kidneys
Normal (C57BL/6J) and MRLFasr kidney slices were snap
frozen in liquid butane and cut on a cryostat at 5 sm. Sections
were transferred onto poly-L-lysine-coated slides and were
stained for IL-12 by indirect immunofluorescence using the rat
anti-mouse mAb 9A5. Sections were fixed briefly in 3% parafor-
maldehyde in 100 mr't cacodyl ate buffer and were blocked with 3%
milk powder (wt/vol) for 15 minutes. After three washes in PBS
sections were then incubated with 9A5 mAb (20 jsg/ml in PBS
containing 3% milk powder) for two hours and were washed again
with PBS. Sections were then incubated for 45 minutes with
FITC-conjugated goat anti-rat IgG (1:50 in PBS containing 3%
milk powder). Before staining, FITC-conjugated goat anti-rat IgG
was adsorbed with 10% mouse serum. Sections were then rinsed
with PBS, mounted with Glycergel® (DAKO, Carpinteria, CA,
USA) containing 25 mg/ml 1,4-diazabicyclo [2.2.2]octane
(DABCO) and examined with a fluorescence microscope.
ELISA for !L-12
The presence of the p75 heterodimer IL-12 protein was mea-
sured in the serum of normal and MRL-Fas" mice, and also in
culture supernatants from LPS-stimulated minced kidneys and
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from TEC using a sensitive and specific ELISA. Free IL-U p40 or
p40 homodimers are not detected with this assay, allowing specific
measurement of the IL-12 p75 heterodimer, even in the presence
of excess p40. Immulon°° A96 ELISA plates were coated over-
night with the rat anti-mouse IL-12 p75 capture mAb 9A5 (5
jig/mi) in 50 m sodium carbonate buffer (pH 9.5) at 4°C. Plates
were washed thrice with wash buffer (PBS containing 0.05%
Tween 20 and 0.01% thimerosal) and were blocked with 3% BSA
for one hour at 37°C. Sample and standard rmulL-12 p75 (100 1.d
aliquots) were then added to the wells. The plates were incubated
at room temperature for two hours, were washed five times, and
were incubated with peroxidase-labeled rat anti-mouse IL-12 p40
mAb 5C3 (0.5 jig/mi) for two hours at room temperature. After
washing the wells five times, the plates were developed with
o-phenylenediamine dihydrochloride (0.4 mg/mi in 50 mrvt phos-
phate-citrate buffer). The reaction was stopped with I M H2S04,
and plates were read at 492 nm on an ELISA reader (Labsystems
Multiskan RC ELISA reader; Labsystems, Helsinki, Finland).
The lower limit of detection of the assay is 15 pg/mi.
Immunofluorescence microscopy analysis of cultured TEC
MCT cells were grown on glass coverslips coated with collagen
until subconfluency. Cells were fixed with 4% paraformaldehyde
for 10 minutes, blocked with 3% milk powder in PBS containing
0.01% Triton X-100 and were then treated with 20 mrvi glycine.
Rat anti-mouse mAb 9A5 (10 jig/mi) in 3% milk powder/PBS was
used to detect membrane-bound IL-12. FITC-conjugated affinity
purified goat anti-rat IgG (Sigma) at 1:50 was used as the
secondary antibody. Cells were then examined by fluorescence
microscopy and photographed.
Results
IL-12 transcrption in normal and in autoimmune MRL-Fas"
tissues
Figure 1 shows the expression of the p35 and p4O IL-12 subunits
by semiquantitative RT-PCR and Southern blot analysis using
total RNA extracted from normal C57BL/6J and from MRL-
Fas'' kidneys. Transcripts for both subunits were detectable in
normal kidney. MRL-Fas4" mice displayed a marked increase in
the steady-state levels for the two subunits, particularly for p40
Fig. 1. Enhanced IL- 12 p35 and p40
transcription is detected by RT-PCR and Southern
blot analysis in nephritic MRL-Fas" mice
compared with uniform transcription of the
housekeeping gene GAPDH. The p35 and p40
fragments were photographed from
autoradiographs (72 hr and 8 hr exposure,
respectively), the GAPDH fragments from an
ethidium bromide stained agarose gel. Lanes 1
to 3, kidneys from normal female C57BL/6J,
lanes 4 to 8, kidneys from MRL-Fas" mice.
The fragment sizes in bp are indicated on the
(up to 10-fold increase). The p35 subunit was slightly higher in
young C57BL/6J compared with older normal mice, whereas
MRL-Fas" displayed enhanced transcript levels with increasing
age and disease activity. Transcripts for the housekeeping gene
GAPDH varied little for all the kidneys examined. Autoradio-
graph exposure times for p40 were three- to fivefold shorter than
for p35 in both normal and MRL-Fas" kidney, indicating that
mRNA levels for p40 are much higher than for p35. Additional
transcripts that are approximately 100 bp larger were detected for
both p35 and p40, presumably generated by alternative splicing.
These larger transcripts were weak in normal and more abundant
in MRLFash1r mice.
We also tested spleen RNA from normal mice, and spleen and
lymph node RNA from MRL-Fas" mice for IL-12 expression by
RT-PCR and Southern blot analysis. Figure 2 demonstrates that
transcripts encoding the p35 and p40 subunits were readily
detected in normal spleen and in MRL-Fas" spleen. Further-
more, IL-12 transcription was ample in the enlarged lymph nodes
of MRL-Fas", suggesting abundant IL-12 transcription in lyrn-
phoid tissues of MRL-Fas". Autoradiograph exposure times were
again longer for p35 than for p40 in lymphoid tissues. As in the
kidney, two transcripts were detected in spleen and lymph node
for p35 and p40.
IL-12 protein in normal and MRL-Fas" mice
To correlate IL-12 transcript levels with immunoreactive IL-12
protein we then examined whether IL-12 p75 could be detected in
normal and in MRL-Fas' kidneys. Figure 3 demonstrates that
IL-12 p75 protein was readily detected in the supernatant of
minced kidney tissue incubated for 18 hours. Supernatants from
MRL-Fas" kidneys had higher levels of IL-12. LPS up-regulated
IL-I 2 slightly in normal but not significantly in MRLFas'1r kidney
(16.5 2.5% [P < 0.05] and 10.5 4.3% [P = NSI, respectively).
Additional experiments comparing congenic MRL-+ + with
MRL-Fas' kidneys also showed that MRL-Fas" kidney pro-
duced higher amounts of IL-12 than MRL-+ + kidney (not
shown).
Immunofluorescence of MRL-Fas" kidney for IL-12 was then
performed to identify the sites of increased renal IL-12 p75
production. Figure 4 demonstrates that cytoplasmic staining for
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Fig. 2. Abundant IL-12 p15 and p40
transcription in spleen from C57BL/6J and MRL-
Fas" and in enlarged lymph nodes from MR.!.-
Fas' mice, compared with lower transcription in
normal and MRL-Fas" kidney (RT-PCR and
Southern blot analysis). The p35 and p40
fragments were photographed from
autoradiographs (7 hr and 1 hr exposure), the
GAPDH fragments from an ethidium bromide
stained agarose gel. Lanes 1 and 2, normal
spleen (S) from C57BL/6J mice. Lanes 3 and 4,
spleen from MRL-Fas1" mice. Lanes 5 and 6,
lymph nodes (LN) from MRL-Fas" mice. Lane
7, normal kidney. Lane 8, MRL-Fas" kidney.
The fragment sizes in bp are indicated on the
right.
Fig. 3. IL-12 p25 heterodimer production by kidney tissue from normal
C57B1-/6J () and autoimmune MRL-Fas" (•) mice (N = 4 in each
group). Kidney tissue was minced and incubated in DMEM media
containing 10% FBS for 18 hours in the presence or absence of LPS (1
jig/mI). Supernatants were harvested and IL-12 content was determined
with the p75-specific ELISA. Data represent mean se. Comparisons
were performed with Student's t-test.
IL-12 was detected on isolated mononuclear cells within large
infiltrates in MRL-Fas" kidney. Staining in these cells was intense
with a primarily cytoplasmic pattern with some membrane accen-
tuation. IL-12 immunostaining was also detected in proximal
tubules in MRL-Fas" kidney, also in a cytoplasmic pattern but
with basolateral accentuation. Weaker IL-12 immunostaining
could also be detected on some TEC in normal kidney (not
shown).
To determine whether IL-12 levels were increased in the
circulation of MRL-Fas we also examined serum from normal
and from MRL-Fas' mice at various ages for the presence of p75
protein by ELISA. Out of 10 normal C57BL/6J mice (age 2 to 5
months) and 15 MRL-Fas (age 4 to 5 months) only one animal
in each group had detectable IL-12 levels, whereas all the other
sera were negative for IL-12 p75 (sensitivity 15 pg/mi). Thus,
Correlation of IL-12 transcription with intrarenal IFN-y mRJVA
Because IL-12 is a potent inducer of IFN-y, we sought to
correlate IL-12 transcript levels with IFN-y mRNA levels in
normal and MRL-Fas' kidneys. IFN-y, IL-12 p35 and p40, and
GAPDH transcript levels were quantitated by densitometiy in
normal and autoimmune MRL-Fas" mice. In Figure 5 the density
ratios of p35 and p40 relative to GAPDH are plotted against the
relative density ratios of IFN-y. Linear regression analysis dem-
onstrates a significant correlation between transcript levels of p35
and IFN-y (r = 0.57, P = 0.04) and also between p40 and IFN-y(r = 0.59, P = 0.03). Therefore, IL-12 and IFN-y transcription
occur together, indicating a link between the two cytokines in
diseased kidney.
!L-12 production by renal TEC
Since TEC in the kidney are a source of IL-12 in vivo, we
determined whether IL-12 production by renal TEC can also be
demonstrated in vitro. We examined primary cultures of mouse
cortical TEC and two SV4O-transformed proximal tubular epithe-
hal cell lines (Cl and MCT) by RT-PCR and Southern blot
analysis for IL-12 p35 and p40 expression. Figure 6 demonstrates
that transcripts encoding p35 and p40 could be detected in all
three TEC types. As in kidney and lymphoid tissues, in addition to
the standard fragments an additional larger fragment was de-
tected for each subunit, presumably generated by alternative
splicing. When TEC were incubated with cycloheximide (5 jig/mI
for 6 hr) superinduction of IL-12 transcript levels were detected
for p40, but not for p35 (Fig. 6).
To correlate IL-12 transcription with p75 protein expression we
performed IL-12 ELISAs on culture supernatants from TEC
(primary cultures, Cl and MCT; Table 1). Low levels of IL-12
could be detected in supernatants of primary cultures, Cl and
MCT cells. Although transcription was easily documented for all
cultured TEC, these cells appear to secrete low amounts of IL-12
even in the presence of LPS. TEC cells were also analyzed for
membrane bound IL-12 using mAb 9A5. Using FACS® analysis
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Fig. 4. Immunofluorescence staining for IL-12 on a five months old female nephritic MRL-Fas" kidney using 9A5 rnAb (20 pg/ml). A. Prominent staining
of isolated mononuclear cells within perivascular infiltrate (arrows) (X400). B. Positive staining of cortical tubules (X400).
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Fig. 5. Correlation of p35 (A) and p40 (B) transcnption in the kidney of noimal (LI) and MRL-Fas" mice ). Dcnsitometrically determined p35/GAPDH
and p40/GAPDH ratios were calculated and are plotted against IFN-y/GAPDH ratios, and linear regression analysis was performed. r = 0.57, P < 0.04.
we were unable to detect cell surface IL-12 on Cl and MCT cells,
presumably because of trypsinization (not shown). An immuno-
fluorescence microscopy was performed to analyze MCT cells
grown on coverslips for membrane bound IL-12 and MCT dis-
played a weak but significant rim staining with the 9A5 mAb,
indicating expression of membrane bound IL-12 on these cells. No
such staining was detected with the irrelevant isotype-matched
anti-CD4 control mAb GK1.5 (not shown).
Discussion
In this study we show for the first time that the pro inflammatory
cytokine IL-12 is markedly up-regulated in the kidney of the
MRL-Fast" model of lupus nephritis. Enhanced renal IL-12
expression is demonstrated in autoimmune mice at a transcrip-
tional level and by immunohistochemistry. IL-12 is not only
produced by infiltrating mononuclear cells in nephritic kidneys,
but also by renal tubular epithelial cells. Furthermore, we find that
IL-12 occurs both as a soluble cytokine and as a membrane-bound
protein on cultured TEC. In MRLFash1r kidney a direct correla-
tion exists between up-regulated IL-12 and its most important
effector cytokine IFN-y. IL-12 may thus be a prominent inducer of
a Thi type of immune response in autoimmune renal injury.
It has been shown that certain organ-specific autoimmune
diseases are caused by a predominant Thi type of immune
response, whereas a Th2 type immune response has inhibitory
effects on autoimmune disease [14, 15]. Typically, Thi cells
produce IFN-y and IL-2, whereas Th2 cells produce IL-4 and IL-5
[10]. Phagocyte-derived IL-12 is a potent inducer of Thi type of
immune responses, whereas Th2 type of immune responses are
promoted by cytokines such as IL-4 and IL-b. The cytokines
produced by each Th cell subset are inhibitory for the opposing
subset, driving CD4+ T cells either towards the Thi or the Th2
phenotype. Analyses of cytokine profiles in murine experimental
allergic encephalomyelitis (EAE) and insulin-dependent diabetes
mellitus (IDDM) have revealed that the onset of disease is
associated with high levels of IL-2 and IFN-y in areas of tissue-
specific injury, reflecting a Thi type of autoimmune response
[34—36].
The role of IL-I 2 in the development of autoimmune responses
is being actively investigated [14]. In the EAE model, a disease
that perhaps follows the most closely the ThlITh2 paradigm,
IL-12 accelerates the disease process, whereas anti-IL-U antibody
treatment substantially retards the development and severity of
the demyelinating lesions [37]. In the collagen-induced arthritis
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Fig. 6. RT-PCR and Southern blot analysis demonstrates the presence of
p.35 and p40 transcripts in TEC. Cells were incubated with or without
cycloheximide (CHX) (5 gJml) for six hours as indicated, RNA was
extracted and RT-PCR followed by Southern blot was performed. The p35
and p40 fragments were photographed from autoradiographs, the
GAPDH fragments from an ethidium bromide stained agarose gel. Lanes
1 and 2, primary cultures of TEC (1° TEC); lanes 3 and 4, Cl cells; lanes
5 and 6, MCT cells. The fragment size in bp is indicated on the right.
model, administration of IL-12 together with collagen type II also
enhances the autoimmune response in an IFN-y-dependent man-
ner, causing severe destructive arthritis in susceptible mice [38].
However, high doses of IL-12 are capable of inhibiting the
autoimmune process, suggesting a differential dose-dependent
effect of IL-12 [39]. This is reminiscent of the variable effects of
IFN-y, the main effector of IL-12 in this disease model of
rheumatoid arthritis [40, 41]. In the NOD autoimmune model of
IDDM, administration of IL-12 induces rapid onset of diabetes in
100% of mice [421. Intermittent administration of IL-12, however,
prevents disease onset in NOD, again showing that IL-12 has
variable effects on autoimmune processes [431. Thus far the role
of IL-12 and the significance of Thi-type immune responses in the
development of SLE have not been addressed.
The cytokine profile in murine SLE has not been fully investi-
gated. It is well known that MRL-Fas" display large amounts of
IL-I, TNF-cs and IFN-yin spleen and lymph nodes [6, 44] and that
nonspecific monokines such as TNF-a and IL-I are characteris-
tically up-regulated in diseased MRL-Fas1 kidneys [8, 9]. Here
we show for the first time that IL-12 and its major effector
cytokine IFN-y are markedly increased in MRL-Fas" kidneys
with autoimmune lesions, suggesting that a Thi-type immune
response occurs in these mice. Furthermore, IL-12 is present
abundantly in lymph nodes and spleen in MRL-Fas", suggesting
that Thi cells are also generated in the peripheral lymphoid
organs.
There is further evidence suggesting that Thi could predomi-
nate over Th2 responses in MRL-Fas".
(1.) Pathogenic T cells comprise the expanded double negative
(CD4—CD8--) and CD4+ T cells in MRL-Fas" mice. Typically
516 these cells produce IFN-y but limited amounts of IL-4 or IL-b,
which is also consistent with a Thi-type of immune response.
IL-12 has been shown to have effects on normal intrathymic T cell
development and to influence hematopoietic stem cell and pro-
genitor cell growth [45, 46], and could thereby influence the
development of the various abnormalities in the hematopoietic
cell system.
(2.) Antinuclear antibody formation and polyclonal B cell
activation are serological hallmarks of murine SLE [2, 3]. Thi
responses favor IgG2 and IgG3 synthesis whereas Th2 responses
are associated with IgG1 and IgE production. In murine SLE,
pathogenic antinuclear antibodies are typically of the IgG2, and
IgG3 subclass, suggesting a predominant Thi type immune re-
sponse [3, 71. The importance of Thi cells in regulating the
anti-Sm response is also suggested by the fact that anti-Sm
antibodies in MRL-Fas" are almost exclusively of the lgG2
subclass [48], and that cryoglobulins causing typical skin lesions in
MRL-Fas" are of IgG3 subclass [49, 50].
(3.) Therapeutic studies in MRL-Fas" have shown dramatic
effects of prostaglandins on the development of the autoimmune
process [51]. Recent studies have examined the interactions
between IL-12 and PGE2 [52]. PGE2 and other inducers of cAMP
inhibit the production of IFN-y by CD4+ T cells and favor the
development of Th2 immune responses [53, 54]. PGE2 also
directly inhibits the production of IL-12 by human monocytes
through a cAMP-dependent intracellular pathway [55]. It is
possible that the prostaglandin effects on murine SLE could be
mediated at least in part by a down-regulation of IL-12 with
subsequent inhibition of Thi immune responses.
Although we cannot exclude participation of Th2 of other types
of T cell responses in murine SLE, the above arguments argue for
a Thi type of immune response in the pathogenesis of MRL-Fas"
lupus nephritis. Our data are consistent with the presence of an
intrarenal Thi type immune in MRL-Fas' lupus nephritis, albeit
we cannot directly prove a direct role of IL-12 in the disease
initiation and progression. We suggest, however, that tubular
epithelial IL-12 could promote a tubulointerstitial immune re-
sponse by stimulating the proliferation and differentiation of
CD4+ Thi T cells.
In addition to macrophage IL-12 production we detected a
substantial increase in IL-12 production by TEC in MRL-Fas"
mice. Thus far only a few other selected non-phagocytic cells have
been shown to produce IL-12 (for example keratinocytes [56, 57]).
TEC have antigen-presenting abilities and express MHC class II
1 2 3 4 5 6
p35
321
p40 415
Table 1. ELISA for IL-12 in culture supernatants
Supernatants from TEC (primary cultures, Cl and MCT) were analyzed
for IL-12 p75 content by a specific ELISA as described in Methods. Data
represent mean values of duplicate determinations.
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molecules abundantly in MRL-Fast". In vitro TEC induce prolif-
eration of appropriate antigen- and MHC-restricted T cell hybrid-
omas [29]. Because of a lack of the major costimulator B7, anergy
is usually obtained for T cell clones [58]. However, we speculate
that IL-12 could promote the development of helper T cell
responses in various autoimmune and infiammatoiy tubulointer-
stitial diseases.
IL-12 secretion by antigen-presenting macrophages together
with appropriate MHC class IIITcR interaction and B7-1/B7-2
costimulation certainly provides a powerful signal to T cells,
generating a Thi type immune response [24, 59]. TEC also have
antigen presenting ability and are capable to interact with T
helper cells [reviewed in 60, 61]. The respective role of mem-
brane-bound and soluble IL-12 on the induction of a Thi type of
immune response in immune renal injury needs to be investigated
further.
In conclusion, we have shown that IL-12 is an important
cytokine in MRL-Fas" lupus nephritis. Its presence correlates
with intrarenal IFN-y transcription and promotes the develop-
ment of a renal-specific Thi type of immune response. In addition
to mononuclear cells, TEC are an important source of IL-12 and
could participate in the pathogenesis of autoimmune renal injury.
The identification of IL-12 production by TEC and its role in
tubulointerstitial renal lesions deserves further investigation.
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